Access to Medicine Index
The Access to Medicine Index, a ranking of pharmaceutical companies’ work to distribute medications to low- and middle-income countries, just named Johnson & Johnson #3 on its biennial list, underscoring the company’s deep history of ensuring people in underserved communities receive the treatments they need.
The company has secured a top ranking on the biennial report—which grades companies on their efforts to make medicine more accessible to those in low- and middle-income countries—for the fourth consecutive time.
The index looks at companies that do the best job of providing access to medications in developing countries. Johnson & Johnson ranked #2—and here’s why.